Activate. Inspire. Motivate.
If you'd like to be an advocate for people with migraine, we'd love to hear your story.
Aimovig is a prescription medicine used to help prevent migraine in adults.
Aimovig is the first and only FDA-approved treatment that blocks the CGRP receptor to help prevent migraine. More about Aimovig.
In clinical studies, people taking Aimovig reduced their monthly migraine days.
The most common side effects of Aimovig include: pain, redness, or swelling at the injection site and constipation.
Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all of the possible side effects of Aimovig. Ask your healthcare provider or pharmacist for more information. Call your healthcare provider for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
Read our Important Safety Information
See the detailed Instructions for Use for complete information on how to take Aimovig.
Do not try to take Aimovig until you have been shown the right way by your healthcare provider. Aimovig is injected under your skin (subcutaneously) 1 time each month. Your healthcare provider will prescribe the dose that is best for you.
If your healthcare provider prescribes you the 70 mg dose, take 1 injection.
If your healthcare provider prescribes you the 140 mg dose, take 2 separate injections, one after another, using a different prefilled autoinjector for each injection.
Acute treatments help to reduce migraine symptoms when they first begin.1
Preventive treatments are used to try and stop migraine symptoms before they start in the first place.1
In Aimovig clinical studies, chronic migraine is defined as 15 or more headache days per month, of which at least 8 were migraine days. An episodic migraine is defined as 4-14 migraine days per month.
The Aimovig Copay Card Program™ can help eligible patients with commercial insurance lower the cost of their treatment. Eligibility Criteria and Program Limits Apply.
Learn more about our Copay Support Options by visiting www.AimovigCopaySupport.com
CGRP stands for calcitonin gene-related peptide.2 There may be a connection between CGRP, CGRP receptors, and migraine.
CGRP receptors can be found on a few different types of cells. The receptors found in the brain are the ones that are thought to be connected to migraine.3
CGRP levels go up during a migraine attack4 and decrease with headache relief.5
Your healthcare provider will determine if Aimovig is right for you. When you go to your appointment, make sure you are prepared with talking points to discuss. Take this quiz to learn more.
1. USDHHS Migraine. 2017 2. Russo. Annu Rev Pharmacol Toxicol. 2015 3. Goadsby. Physiol Rev. 2017 4. Goadsby. Ann Neurol. 1990 5. Goadsby. Ann Neurol. 1993
8:00 am–8:00 pm ET, Mon-Fri.
Excludes public holidays
Before starting Aimovig™ (erenumab-aooe), tell your healthcare provider about all your medical conditions, including if you are allergic to rubber or latex, pregnant or plan to become pregnant, breastfeeding or plan to breastfeed.
Tell your healthcare provider or pharmacist about all the medicines you take, including any prescription and over-the-counter medicines, vitamins, or herbal supplements.
What are possible side effects of Aimovig™?
The most common side effects of Aimovig™ are pain, redness, or swelling at the injection site and constipation.
Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all of the possible side effects of Aimovig™. Ask your healthcare provider or pharmacist for more information. Call your healthcare provider for medical advice about side effects.
You are encouraged to report side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Aimovig™ is a prescription medicine used for the preventive treatment of migraine in adults.